Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer.

Bai S, Taylor SE, Jamalruddin MA, McGonigal S, Grimley E, Yang D, Bernstein KA, Buckanovich RJ
Mol Cancer Ther. 2022 Sep 6;21(9):1473-1484. doi: 10.1158/1535-7163.MCT-21-0873. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.